Clinical Trials

Search Form

Disease Site Trial Sort descending Trial Description Trial Status Lead Cooperative Group
Endometrial PORTEC-4a

Randomised Phase III Trial of molecular profile-based versus standard recommendations for adjuvant radiotherapy for women with early stage endometrial cancer

Closed to Recruitment DGOG
Endometrial Rainbo-MMRd-GREEN

Rainbo: Refining adjuvant treatment IN endometrial cancer based on molecular features, transportec platform trials - MMRd - Green

Recruiting DGOG
Endometrial SAVE

Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care (SAVE)

Recruiting COGI-WCRN
Endometrial STATEC

A randomised trial of non-Selective versus selective adjuvant Therapy in high risk Apparent sTage 1 Endometrial Cancer

Completed NCRI
Endometrial TOTEM

Trial between Two Follow up Regimens with Different Intensity in Endometrial Cancer Treated Patients

Completed MaNGO
Fallopian Tube & Ovarian VIP

Phase II Study of Intravenous Vinorelbine in Patients With Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Recruiting GCGS
Gestational Trophoblastic Neoplasia GOG 0275

Dactinomycin or Methotrexate in Treating Patients with Low Risk Gestational Trophoblastic Neoplasia

Recruiting GOG-F
Ovarian AGO – OVAR OP.3 (LION)

Lymphadenectomy In Ovarian Neoplasms

Completed AGO
Ovarian AGO-OVAR 28

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane based Chemotherapy in Advanced Ovarian Cancer

Recruiting AGO

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer (TRUST)

Follow Up AGO
Ovarian AGO-OVAR12 (BI 1199.15)

Multicenter, randomised, double-blind phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and paclitaxel in patients with advanced ovarian cancer

Completed AGO
Ovarian AGO-OVAR16 (VEG110655)

A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy versus Placebo in Women who have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Completed AGO
Ovarian AGO-OVAR17

Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer (BOOST)

Completed AGO
Ovarian AGO-OVAR23/DUO-O

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib

Follow Up AGO
Ovarian ANITA/ ENGOT-Ov41/ GEICO 69-O

A phase III randomized, double-blinded trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal or peritoneal cancer and platinum treatment-free interval (TFIp) >6 months 

Closed to Recruitment GEICO
Ovarian AURELIA (GCIG/Roche)

A multi-centre, open-label, randomised, two-arm Phase III trial of bevacizumab plus chemotherapy versus chemotherapy alone in patients with platinum-resistant, epithelial ovarian, fallopian tube or primary peritoneal cancer 

Completed GINECO
Ovarian CCTG OV.21

A phase II/III study of intraperitoneal (IP) plus intravenous (IV) chemotherapy versus IV carboplatin plus paclitaxel in patients with epithelial ovarian cancer optimally debulked at surgery following neoadjuvant intravenous chemotherapy 

Completed CCTG
Ovarian CCTG OV.25, STICS and STONES

A randomized phase II double-blind placebo-controlled trial of Acetylsalicylic acid (ASA) in chemoprevention of ovarian cancer in women with BRCA1/2 mutations

Closed to Recruitment CCTG
Ovarian CHORUS

A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma

Completed NCRI
Ovarian CHRONO

Retarded surgery following neoadjuvant chemotherapy in advanced ovarian cancer

Recruiting GINECO